621
Participants
Start Date
November 1, 2009
Primary Completion Date
March 23, 2012
Study Completion Date
March 23, 2012
Mepolizumab 750
Mepolizumab 750mg every four weeks by i.v.
Mepolizumab 250
Mepolizumab 250mg every four weeks by i.v.
Mepolizumab 75
Mepolizumab 75mg every four weeks by i.v.
Placebo saline
Placebo saline every four weeks by i.v.
GSK Investigational Site, Buenos Aires
GSK Investigational Site, New Lambton
GSK Investigational Site, Melbourne
GSK Investigational Site, Clayton
GSK Investigational Site, San Miguel de Tucumán
GSK Investigational Site, Adelaide
GSK Investigational Site, Nedlands
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Marseille
GSK Investigational Site, Berlin
GSK Investigational Site, Rüdersdorf
GSK Investigational Site, Hershey
GSK Investigational Site, Cherkassy
GSK Investigational Site, Lübeck
GSK Investigational Site, Winston-Salem
GSK Investigational Site, Charleston
GSK Investigational Site, Albany
GSK Investigational Site, Columbus
GSK Investigational Site, Montpellier
GSK Investigational Site, Nashville
GSK Investigational Site, Magdeburg
GSK Investigational Site, Lexington
GSK Investigational Site, Nantes
GSK Investigational Site, Cleveland
GSK Investigational Site, Canton
GSK Investigational Site, Dnipropetrovsk
GSK Investigational Site, Dnipropetrovsk
GSK Investigational Site, Dnipropetrovsk
GSK Investigational Site, Madison
GSK Investigational Site, Mykolayiv
GSK Investigational Site, Mainz
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Kharkiv
GSK Investigational Site, St Louis
GSK Investigational Site, Bucharest
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Houston
GSK Investigational Site, Boerne
GSK Investigational Site, Denver
GSK Investigational Site, Donetsk
GSK Investigational Site, Donetsk
GSK Investigational Site, Los Angeles
GSK Investigational Site, Long Beach
GSK Investigational Site, Clamart
GSK Investigational Site, Riverside
GSK Investigational Site, Saint-Pierre
GSK Investigational Site, Moscow
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Kazan'
GSK Investigational Site, Chelyabinsk
GSK Investigational Site, Târgu Mureş
GSK Investigational Site, Tomsk
GSK Investigational Site, Iași
GSK Investigational Site, Valparaíso
GSK Investigational Site, Talcahuano
GSK Investigational Site, Puente Alto - Santiago
GSK Investigational Site, Santiago
GSK Investigational Site, San Diego
GSK Investigational Site, New Haven
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Mar del Plata
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Mendoza
GSK Investigational Site, Calgary
GSK Investigational Site, Vancouver
GSK Investigational Site, Mississauga
GSK Investigational Site, Mississauga
GSK Investigational Site, Québec
GSK Investigational Site, Bialystok
GSK Investigational Site, Lodz
GSK Investigational Site, Warsaw
GSK Investigational Site, Wroclaw
GSK Investigational Site, Zawadzkie
GSK Investigational Site, Zgierz
GSK Investigational Site, Bucharest
GSK Investigational Site, Barnaul
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Bucheon-si
GSK Investigational Site, Cheongju, Chungcheongbuk-do
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Suwon, Kyonggi-do
GSK Investigational Site, Kiev
GSK Investigational Site, Kyiv
GSK Investigational Site, Kyiv
GSK Investigational Site, Leicester
GSK Investigational Site, London
GSK Investigational Site, London
GSK Investigational Site, Manchester
GSK Investigational Site, Southampton
Lead Sponsor
GlaxoSmithKline
INDUSTRY